Edwards Lifesciences Corporation
MX ˙ BMV ˙ US28176E1082
SecurityMX:EW / Edwards Lifesciences Corporation
InstitutionAlly Financial Inc.
Latest Disclosed Ownership13,000 shares
Latest Disclosed Value $ 1,041,040
Ally Financial Inc. ownership in EW / Edwards Lifesciences Corporation

On May 12, 2026 - Ally Financial Inc. filed a 13F-HR form disclosing ownership of 13,000 shares of Edwards Lifesciences Corporation (MX:EW) valued at $1,041,040 USD as of March 31, 2026. The entity filed a previous 13F-HR on August 13, 2025 disclosing 0 shares of Edwards Lifesciences Corporation.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-12 2026-03-31 13F Edwards Lifesciences COM 28176E108 13,000 13,000 1,041 0.1295
2025-08-13 2025-06-30 13F Edwards Lifesciences COM 28176E108 0 -15,000 -100.00 0 -100.00
2025-05-14 2025-03-31 13F Edwards Lifesciences COM 28176E108 15,000 0 0.00 1,087 -2.07 0.1220
2025-02-13 2024-12-31 13F Edwards Lifesciences COM 28176E108 15,000 0 0.00 1,110 12.23 0.1354
2024-11-13 2024-09-30 13F Edwards Lifesciences COM 28176E108 15,000 15,000 990 0.1196
2024-08-13 2024-06-30 13F Edwards Lifesciences COM 28176E108 0 -6,000 -100.00 0 -100.00
2024-05-14 2024-03-31 13F Edwards Lifesciences COM 28176E108 6,000 0 0.00 573 25.38 0.0774
2024-02-13 2023-12-31 13F Edwards Lifesciences COM 28176E108 6,000 0 0.00 458 10.12 0.0598
2023-11-13 2023-09-30 13F Edwards Lifesciences COM 28176E108 6,000 6,000 416 0.0611
2014-08-14 2014-06-30 13F Edwards Lifesciences COM 28176E108 0 -35,000 -100.00 0 -100.00
2014-05-15 2014-03-31 13F Edwards Lifesciences COM 28176E108 35,000 25,000 250.00 2,596 294.53 0.2766
2014-02-14 2013-12-31 13F Edwards Lifesciences COM 28176E108 10,000 10,000 658 0.0700
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.